Article Versions Notes

Habermann F-NOJ, Schmitt D, Failing T, Fischer J, Ziegler DA, Fischer LA, Alt NJ, Muster J, Donath S, Hille A, et al. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Current Oncology. 2022; 29(2):1080-1092. https://doi.org/10.3390/curroncol29020092

Habermann, Felix-Nikolai Oschinka Jegor, Daniela Schmitt, Thomas Failing, Jann Fischer, David Alexander Ziegler, Laura Anna Fischer, Niklas Josua Alt, Julian Muster, Sandra Donath, Andrea Hille, and et al. 2022. "Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes" Current Oncology 29, no. 2: 1080-1092. https://doi.org/10.3390/curroncol29020092

Habermann, F.-N. O. J., Schmitt, D., Failing, T., Fischer, J., Ziegler, D. A., Fischer, L. A., Alt, N. J., Muster, J., Donath, S., Hille, A., Schirmer, M. A., Guhlich, M., El Shafie, R. A., Rieken, S., Leu, M., & Dröge, L. H. (2022). Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Current Oncology, 29(2), 1080-1092. https://doi.org/10.3390/curroncol29020092